Actos Bladder Cancer Lawsuit Update: Jury Awards $9 Billion in 1st MDL Actos Bladder Cancer Bellweth

Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay a total of $9 billion in punitive damages after they were found to have concealed diabetes drug, Actos’, cancer risks. Parker Waichman LLP continues to evaluate cases of bladder cancer in patients who allege serious injuries associated with Actos. New York, New York (PRWEB) April 08, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, reports that Takeda Pharmaceutical Co. was ordered to pay $6 billion, and Eli Lilly & Co. was ordered to pay
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations